Recombinant multi-species CARD11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CARD11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the membrane-associated guanylate kinase (MAGUK) family, a class of proteins that functions as molecular scaffolds for the assembly of multiprotein complexes at specialized regions of the plasma membrane. This protein is also a member of the CARD protein family, which is defined by carrying a characteristic caspase-associated recruitment domain (CARD). This protein has a domain structure similar to that of CARD14 protein. The CARD domains of both proteins have been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. When expressed in cells, this protein activated NF-kappaB and induced the phosphorylation of BCL10. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 0610008L17Rik,2410011D02Rik,BENTA,BIMP3,CARD-containing MAGUK protein 1 (Carma 1),CARD11,CARMA1,Card11,Caspase recruitment domain-containing protein 11,IMD11,IMD11A,PPBL

Target products collectionGo to CARD11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12925-Ag-1/ GM-Tg-hg-IP12925-Ag-2 Human CARD11 protein Human
GM-Tg-rg-IP12925-Ag-1/ GM-Tg-rg-IP12925-Ag-2 Rat CARD11 protein Rat
GM-Tg-mg-IP12925-Ag-1/ GM-Tg-mg-IP12925-Ag-2 Mouse CARD11 protein Mouse
GM-Tg-cynog-IP12925-Ag-1/ GM-Tg-cynog-IP12925-Ag-2 Cynomolgus/Rhesus macaque CARD11 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12925-Ag-1/ GM-Tg-felg-IP12925-Ag-2 Feline CARD11 protein Feline
GM-Tg-cang-IP12925-Ag-1/ GM-Tg-cang-IP12925-Ag-2 Canine CARD11 protein Canine
GM-Tg-bovg-IP12925-Ag-1/ GM-Tg-bovg-IP12925-Ag-2 Bovine CARD11 protein Bovine
GM-Tg-equg-IP12925-Ag-1/ GM-Tg-equg-IP12925-Ag-2 Equine CARD11 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12925-Ag-1/ GM-Tg-hg-IP12925-Ag-2; GM-Tg-rg-IP12925-Ag-1/ GM-Tg-rg-IP12925-Ag-2;
GM-Tg-mg-IP12925-Ag-1/ GM-Tg-mg-IP12925-Ag-2; GM-Tg-cynog-IP12925-Ag-1/ GM-Tg-cynog-IP12925-Ag-2;
GM-Tg-felg-IP12925-Ag-1/ GM-Tg-felg-IP12925-Ag-2; GM-Tg-cang-IP12925-Ag-1/ GM-Tg-cang-IP12925-Ag-2;
GM-Tg-bovg-IP12925-Ag-1/ GM-Tg-bovg-IP12925-Ag-2; GM-Tg-equg-IP12925-Ag-1/ GM-Tg-equg-IP12925-Ag-2
Products Name CARD11 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CARD11
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CARD11 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.